Rana H, Truong N, Sirimanne D, Cunningham A
Viruses. 2024; 16(11).
PMID: 39599904
PMC: 11599041.
DOI: 10.3390/v16111790.
Zhang Y, Tian L
Heliyon. 2024; 10(20):e39148.
PMID: 39492906
PMC: 11530831.
DOI: 10.1016/j.heliyon.2024.e39148.
Zheng F, Du Y, Yuan Y, Wang Z, Li S, Xiong S
Heliyon. 2024; 10(18):e37544.
PMID: 39309793
PMC: 11415710.
DOI: 10.1016/j.heliyon.2024.e37544.
Zhang L, Wei X
Biol Rev Camb Philos Soc. 2024; 100(1):445-460.
PMID: 39308450
PMC: 11718597.
DOI: 10.1111/brv.13147.
Barragan-Galvez J, Hernandez-Flores A, Lopez-Ortega O, Rodriguez-Alvarez A, Maravillas-Montero J, Ortiz-Navarrete V
Biochem Biophys Rep. 2024; 39:101813.
PMID: 39263316
PMC: 11388666.
DOI: 10.1016/j.bbrep.2024.101813.
Post-marketing drug safety surveillance of enfortumab vedotin: an observational pharmacovigilance study based on a real-world database.
Yu M, Zhou L, Cao M, Ji C, Zheng Y
Front Immunol. 2024; 15:1397692.
PMID: 39234238
PMC: 11372787.
DOI: 10.3389/fimmu.2024.1397692.
High aggressiveness of papillary thyroid cancer: from clinical evidence to regulatory cellular networks.
Zhang J, Xu S
Cell Death Discov. 2024; 10(1):378.
PMID: 39187514
PMC: 11347646.
DOI: 10.1038/s41420-024-02157-2.
The Nectin family ligands, PVRL2 and PVR, in cancer immunology and immunotherapy.
Murakami K, Ganguly S
Front Immunol. 2024; 15:1441730.
PMID: 39156900
PMC: 11327090.
DOI: 10.3389/fimmu.2024.1441730.
Antibody-drug conjugates in cancer therapy: mechanisms and clinical studies.
He J, Zeng X, Wang C, Wang E, Li Y
MedComm (2020). 2024; 5(8):e671.
PMID: 39070179
PMC: 11283588.
DOI: 10.1002/mco2.671.
Tigilanol Tiglate-Induced Changes in Secretome Profiles Alter C-Met Phosphorylation and Cell Surface Protein Expression in H357 Head and Neck Cancer Cells.
Antwi F, Awad T, Larin M, Heesom K, Lewis P, Reddell P
Cells. 2024; 13(11.
PMID: 38891113
PMC: 11171882.
DOI: 10.3390/cells13110982.
The Tumor Microenvironment: Signal Transduction.
Zhang X, Ma H, Gao Y, Liang Y, Du Y, Hao S
Biomolecules. 2024; 14(4).
PMID: 38672455
PMC: 11048169.
DOI: 10.3390/biom14040438.
Necl-1/CADM3 regulates cone synapse formation in the mouse retina.
Kawashima R, Matsushita K, Mandai K, Sugita Y, Maruo T, Mizutani K
iScience. 2024; 27(4):109577.
PMID: 38623325
PMC: 11016759.
DOI: 10.1016/j.isci.2024.109577.
CD112 Supports Lymphatic Migration of Human Dermal Dendritic Cells.
Haghayegh Jahromi N, Gkountidi A, Collado-Diaz V, Blatter K, Bauer A, Zambounis L
Cells. 2024; 13(5.
PMID: 38474388
PMC: 10931060.
DOI: 10.3390/cells13050424.
Interferon-stimulated gene PVRL4 broadly suppresses viral entry by inhibiting viral-cellular membrane fusion.
Cai Q, Sun N, Zhang Y, Wang J, Pan C, Chen Y
Cell Biosci. 2024; 14(1):23.
PMID: 38368366
PMC: 10873969.
DOI: 10.1186/s13578-024-01202-y.
Production and characterization of single-chain variable fragment antibodies targeting the breast cancer tumor marker nectin-4.
Liu C, Leu S, Lee C, Lin C, Wang W, Tsai B
Front Immunol. 2024; 14:1292019.
PMID: 38288120
PMC: 10822971.
DOI: 10.3389/fimmu.2023.1292019.
Construction of an Exudative Age-Related Macular Degeneration Diagnostic and Therapeutic Molecular Network Using Multi-Layer Network Analysis, a Fuzzy Logic Model, and Deep Learning Techniques: Are Retinal and Brain Neurodegenerative Disorders....
Latifi-Navid H, Behrooz A, Jamehdor S, Davari M, Latifinavid M, Zolfaghari N
Pharmaceuticals (Basel). 2023; 16(11).
PMID: 38004422
PMC: 10674956.
DOI: 10.3390/ph16111555.
Prognostic Potential of Nectin Expressions in Colorectal Cancer: An Exploratory Study.
Kobecki J, Gajdzis P, Mazur G, Chabowski M
Int J Mol Sci. 2023; 24(21).
PMID: 37958883
PMC: 10650805.
DOI: 10.3390/ijms242115900.
CD155 and Its Receptors as Targets for Cancer Therapy.
Paolini R, Molfetta R
Int J Mol Sci. 2023; 24(16).
PMID: 37629138
PMC: 10455395.
DOI: 10.3390/ijms241612958.
Tumour follower cells: A novel driver of leader cells in collective invasion (Review).
Wang X, Tang Y, Liang X
Int J Oncol. 2023; 63(4).
PMID: 37615176
PMC: 10552739.
DOI: 10.3892/ijo.2023.5563.
Increased levels of nectin-4 as a serological marker for pre-eclampsia.
Yoshizawa H, Nishizawa H, Ito M, Ohwaki A, Sakabe Y, Sekiya T
Fujita Med J. 2023; 9(3):200-205.
PMID: 37554937
PMC: 10405896.
DOI: 10.20407/fmj.2022-027.